Status:
COMPLETED
Evaluation of the Right Use of Inhaled Therapeutics
Lead Sponsor:
Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
Conditions:
COPD Asthma
Eligibility:
All Genders
18+ years
Brief Summary
Asthma and COPD have a significant impact on public health, affecting about 8 million people in France and generating health care costs of 5.5 billion euros, almost 50% of which are dedicated to long-...
Eligibility Criteria
Inclusion
- Patient followed in Pneumology for asthma or COPD with a prescription for long-term inhaled therapies AND a home health provider (who monitors either home oxygen and / or respiratory equipment)
- The patient must have a means of telephone communication in order to be able to be contacted by a provider, an H2AD permanence or a doctor
- Patient having given his agreement after having been informed in writing of the purpose and the data collected during this study
- Age ≥ 18 years
- Beneficiary of a social security scheme
Exclusion
- Refusal of the patient
- Patient not understanding French
- Absence of home health provider
- Absence of means of telephone communication
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03395418
Start Date
December 1 2017
End Date
November 1 2019
Last Update
March 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ANTADIR
Paris, France, 75006